MaxCyte Sustainability Profile
MaxCyte, Inc., a leading player in the cell engineering industry, is headquartered in the United States, with significant operations across Europe and Asia. Founded in 1998, the company has established itself as a pioneer in the development of cell-based therapies and drug discovery solutions. MaxCyte's core offerings include its proprietary Flow Electroporation® technology, which enables the efficient delivery of nucleic acids into various cell types. This unique approach not only enhances the development of cell therapies but also accelerates the discovery of new drugs. With a strong market position, MaxCyte has achieved notable milestones, including partnerships with major pharmaceutical companies and biotechs, solidifying its reputation as a trusted provider in the biopharmaceutical sector.
DitchCarbon Score
How does MaxCyte's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Metal Fabrication industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MaxCyte's score of 20 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MaxCyte's reported carbon emissions
MaxCyte, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that MaxCyte may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within a sector increasingly focused on sustainability, it may benefit from developing clear climate commitments and reduction strategies to align with industry best practices and stakeholder expectations.
How Carbon Intensive is MaxCyte's Industry?
How Carbon Intensive is MaxCyte's Location?
MaxCyte's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MaxCyte has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
